Chronic Pressure Ulcers

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Organogenesis
OrganogenesisCANTON, MA
1 program
PuraPly® Antimicrobial Wound MatrixN/A1 trial
Active Trials
NCT03502824TerminatedEst. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OrganogenesisPuraPly® Antimicrobial Wound Matrix

Clinical Trials (1)

NCT03502824OrganogenesisPuraPly® Antimicrobial Wound Matrix

PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.

Start: May 2018Est. completion: Sep 2021
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space